Firstsource Solutions / Q3-FY26

Read the quarter in context.

A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

Positive2026-01-20Back to FIRSTSOURCESOLUTIONS

Revenue

₹2,443 Cr

verified against source

Revenue YoY

16.2%

reported change

EBITDA

Pending

latest reported figure

Source

screener in

record provenance

Actual signal trajectory

Where this quarter sits.

source records only
PAT (₹ Cr)PositiveWatchNegative
1 actual records
Actual quarterly PAT (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q3 FY26: 120 · Positive source sentiment · 2026-01-20Q3 FY26120120
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.

Quarter read

What the record says.

Firstsource Solutions delivered a strong Q3 FY26 with revenue of ₹2,444 crore, up 16.2% YoY, driven by broad-based demand across verticals and five large deal wins. EBIT margin expanded 80 bps YoY to 11.9%, marking the fifth consecutive quarter of margin expansion. Adjusted PAT grew 26% YoY to ₹200 crore. Management raised FY26 constant currency revenue guidance to 13-14% organically (14.5-15% including acquisitions) and EBIT margin guidance to 11.5-12%. Key growth drivers include strong deal pipeline (>$1B), strategic acquisitions (Past Due Credit, Telemetic), and offshore shift. Risk: potential US healthcare regulatory headwinds (CMS rate freeze) could pressure payer clients, though management sees this as a tailwind for outsourcing.

Colored figures show movement against the previous available record.

Guidance to track

  • Management raised organic CC revenue growth guidance to 13-14% (from earlier ~14% midpoint) and to 14.5-15% including Past Due Credit and Telemetic acquisitions.
  • EBIT margin guidance for FY26 raised to 11.5-12% from earlier 11.25-12%, reflecting strong execution and margin expansion trajectory.
  • Management reiterated aspiration to reach 14-15% EBIT margin over the next 3-4 years, with 50-75 bps annual expansion.
  • Management expects Q4 FY26 constant currency revenue growth to be higher sequentially, consistent with upward trajectory through the year.

Risks flagged

  • CMS proposal to keep Medicare Advantage rates largely unchanged could pressure payer margins, potentially reducing outsourcing spend. Management sees it as a tailwind but acknowledges uncertainty.
  • US proposal to cap credit card late payment fees could impact collections business unit economics. Management downplays near-term impact but notes medium-term ambiguity.
  • Planned trimming of low-margin, low-growth provider accounts may weigh on healthcare vertical growth in the short term (~50 bps revenue impact in FY26).
  • Continued shift of work from onshore to offshore/nearshore locations (e.g., UK to South Africa) may dampen reported revenue growth despite volume growth.

Key quotes

  • Our sales engine is working well. We had five large deal wins in Q3 which now is the fourth straight quarter of four or more large deals.
  • We now expect our constant currency revenue growth for FI26 to be in the 13 to 14% range. This does not include the recent past due credit solutions and telemetic acquisitions.
  • Our view is that this should lead to not just more outsourcing but also more offshoring and clients looking for more transformational programs that give them a structural uplift in their cost structures.

Research modules

Go one layer deeper.